These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8357875)

  • 1. Simultaneous determination of a new anticancer drug galocitabine and its metabolites in blood by high-performance liquid chromatography.
    Funaki T; Onodera H; Ogawa K; Ichihara S; Fukazawa H; Kuruma I
    J Pharm Biomed Anal; 1993; 11(4-5):379-84. PubMed ID: 8357875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of capecitabine and its three nucleoside metabolites in human plasma by high performance liquid chromatography-tandem mass spectrometry.
    Deng P; Ji C; Dai X; Zhong D; Ding L; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 989():71-9. PubMed ID: 25808944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma.
    Vainchtein LD; Rosing H; Schellens JH; Beijnen JH
    Biomed Chromatogr; 2010 Apr; 24(4):374-86. PubMed ID: 19650151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and simultaneous determination of capecitabine and its metabolites in mouse plasma, mouse serum, and in rabbit bile by high-performance liquid chromatography.
    Dhananjeyan MR; Liu J; Bykowski C; Trendel JA; Sarver JG; Ando H; Erhardt PW
    J Chromatogr A; 2007 Jan; 1138(1-2):101-8. PubMed ID: 17070825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a simple assay for the quantification of the capecitabine metabolites 5'-DFCR and 5'-DFUR for drug monitoring in patients receiving outpatient chemotherapy.
    Buchner P; Mihola E; Sahmanovic A; Steininger T; Dittrich C; Czejka M
    Anticancer Res; 2013 Mar; 33(3):881-6. PubMed ID: 23482757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).
    Knikman JE; de Vries N; Rosing H; Cats A; Guchelaar HJ; Beijnen JH
    Pharmazie; 2023 Aug; 78(8):107-112. PubMed ID: 37592424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients.
    Reigner B; Verweij J; Dirix L; Cassidy J; Twelves C; Allman D; Weidekamm E; Roos B; Banken L; Utoh M; Osterwalder B
    Clin Cancer Res; 1998 Apr; 4(4):941-8. PubMed ID: 9563888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5'-deoxy-5-fluorouridine against adenocarcinoma 755 in mice. Correlation with pharmacokinetics of plasma 5-fluorouracil levels.
    Iigo M; Nishikata K; Nakajima Y; Hoshi A; Okudaira N; Odagiri H; De Clercq E
    Biochem Pharmacol; 1989 Jun; 38(12):1885-9. PubMed ID: 2525905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatography.
    Schaaf LJ; Ferry DG; Hung CT; Perrier DG; Edwards IR
    J Chromatogr; 1985 Aug; 342(2):303-13. PubMed ID: 2932458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of capecitabine and its six metabolites in human plasma using liquid chromatography coupled to electrospray tandem mass spectrometry.
    Deenen MJ; Rosing H; Hillebrand MJ; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jan; 913-914():30-40. PubMed ID: 23270936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma disposition of capecitabine (CCB) and its metabolites 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouracil (5'-DFUR) with two different capecitabine/oxaliplatin dosage regimens.
    Farkouh A; Schueller J; Scheithauer W; Czejka M
    Int J Clin Pharmacol Ther; 2010 Jul; 48(7):487-8. PubMed ID: 20557855
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between AUC of 5'-DFUR and toxicity of capecitabine, fluoropyrimidine carbamate analogs, and 5'-DFUR in monkeys, mice, and rats.
    Shindoh H; Kawashima A; Shishido N; Nakano K; Kobayashi K; Horii I
    J Toxicol Sci; 2006 Aug; 31(3):265-85. PubMed ID: 16960436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic modelling of 5-FU production from capecitabine--a population study in 40 adult patients with metastatic cancer.
    Urien S; Rezaí K; Lokiec F
    J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):817-33. PubMed ID: 16284918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple determination of capecitabine and its metabolites by liquid chromatography with ultraviolet detection in a single injection.
    Zufía L; Aldaz A; Giráldez J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):51-8. PubMed ID: 15282093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of 5-fluorouracil and its main metabolites in plasma by high-performance liquid chromatography.
    Barberi-Heyob M; Merlin JL; Webér B
    J Chromatogr; 1992 Jan; 573(2):247-52. PubMed ID: 1534812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase extraction of fluoropyrimidine derivatives on a copper-modified strong cation exchanger: determination of doxifluridine, 5-fluorouracil and its main metabolites in serum by high-performance liquid chromatography with ultraviolet detection.
    Guerrieri A; Palmisano F; Zambonin PG; De Lena M; Lorusso V
    J Chromatogr; 1993 Jul; 617(1):71-7. PubMed ID: 8376540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5'-deoxy-5-fluorocytidine formation.
    Tabata T; Katoh M; Tokudome S; Hosakawa M; Chiba K; Nakajima M; Yokoi T
    Drug Metab Dispos; 2004 Jul; 32(7):762-7. PubMed ID: 15205393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variations in the pharmacokinetics of capecitabine and its metabolites in rats.
    Kobuchi S; Yazaki Y; Ito Y; Sakaeda T
    Eur J Pharm Sci; 2018 Jan; 112():152-158. PubMed ID: 29175408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of 5'-deoxy-5-fluorouridine (5'-DFUR) by high-performance liquid chromatography and studies on pharmacokinetics of 5'-DFUR and 5-fluorouracil by oral and intravenous administration].
    Hara Y; Kono A; Tanaka M
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2261-6. PubMed ID: 6237614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of coadministered uridine on intestinal first-pass metabolism of 5'-deoxy-5-fluorouridine in conscious rats--an evaluation by method of portal-systemic concentration difference.
    Sawai Y; Yamaoka K; Nakagawa T
    Pharm Res; 1998 Jul; 15(7):1007-11. PubMed ID: 9688052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.